Renee Gala

President and CEO, Jazz Pharmaceuticals

Dublin, Ireland

About

Renee Gala is the President, Chief Executive Officer and a director of Jazz Pharmaceuticals, a global biopharmaceutical company headquartered in Dublin, Ireland that develops and sells medicines for rare diseases, including treatments for epilepsy, cancer and sleep disorders. She became CEO in August 2025, after serving as the company's Chief Operating Officer and Chief Financial Officer.

Gala holds a B.S. in Mathematics from Vanderbilt University and an M.B.A. from Columbia Business School. She worked in the energy industry in corporate finance and mergers and acquisitions, then at Eli Lilly from 2001 to 2006 and at Theravance from 2006, where she became Chief Financial Officer of Theravance Biopharma in December 2014. She was CFO of GRAIL in 2019, joined Jazz as CFO in March 2020, and became President and Chief Operating Officer in October 2023. She succeeded Bruce Cozadd, who had been CEO since 2012. Other biotech and pharmaceutical chief executives with pages on Whoo include Chris Viehbacher of Biogen and Leonard Schleifer of Regeneron.

Whoo compiled this page from public sources: Jazz 2026 proxy statement (SEC), Jazz Form 10-Q, September 2026 (SEC), Jazz Form 10-K, 2025 (SEC). It is not affiliated with or endorsed by Renee Gala. Are you Renee Gala? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

President and Chief Executive Officer — Jazz Pharmaceuticals


August 2025 – Present | Dublin, Ireland

  • Also serves as a director
  • President and Chief Operating Officer — Jazz Pharmaceuticals


    October 2023

    Executive Vice President and Chief Financial Officer — Jazz Pharmaceuticals


    March 2020

    Chief Financial Officer — GRAIL, Inc.


    January – June 2019

    Senior Vice President and Chief Financial Officer — Theravance Biopharma


    December 2014 – January 2019

  • Joined Theravance in 2006

Treasury, sales and corporate development roles — Eli Lilly and Company


2001 – 2006

Education

BS in Mathematics — Vanderbilt University

MBA — Columbia Business School

Projects